Combination vaccines hold potential in the South African pediatric market

Combination pediatric vaccines are rapidly climbing the technology ladder as they have the ability to increase the immunization coverage rate by lowering the amount of injections needed. Unfortunately, however, the South African public sector has limited access to this technology due to its slow adoption rate of new science, as well as cost constraints.

Manufacturers are therefore challenged to lower their production costs and to shift their revenue models to high-volume, low-margin products to suit the needs of the public sector and vaccinate the South African population against the necessary range of diseases.

$33.2B market to double by 2012